Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.
about
Low Dose Spironolactone Monotherapy in the Management of Stage I Essential Hypertension: A Pilot Randomized, Double-Blind, Placebo-Controlled Trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Low Dose Spironolactone Monoth ...... ind, Placebo-Controlled Trial.
@en
Low Dose Spironolactone Monoth ...... ind, Placebo-Controlled Trial.
@nl
type
label
Low Dose Spironolactone Monoth ...... ind, Placebo-Controlled Trial.
@en
Low Dose Spironolactone Monoth ...... ind, Placebo-Controlled Trial.
@nl
prefLabel
Low Dose Spironolactone Monoth ...... ind, Placebo-Controlled Trial.
@en
Low Dose Spironolactone Monoth ...... ind, Placebo-Controlled Trial.
@nl
P2860
P1476
Low Dose Spironolactone Monoth ...... ind, Placebo-Controlled Trial.
@en
P2093
Amir-Abbas Sadeghi
Fatemeh Amirmoezi
P2860
P356
10.6515/ACS.201801_34(1).20170903B
P577
2018-01-01T00:00:00Z